On December 18, 2023, the U.S. Environmental Protection Agency (EPA) issued Regulation 2023-27654 establishing temporary maximum residue limits for Kasugamycin in certain products.

The proposed amendments are as follows:

It is understood that this provision takes effect on December 18, 2023, and the objection or hearing request needs to be filed by February 16, 2024.